newsfilter
← Latest News
GlobeNewswire·

Polyrizon Reports Successful Intranasal Delivery of PL-14 Allergy Blocker in Latest Study

Ra'anana, Israel, July 22, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ:PLRZ) ("Polyrizon" or the "Company"), a biotechnology company focusing on the development of intranasal products, today announced encouraging